Paul L. Jenkinson serves as Executive at Kite Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Paul L. Jenkinson has executed 7 insider transactions totaling $420.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 3, 2017 involved selling 9,462 shares valued at $0.
Paul L. Jenkinson currently holds 9,462 shares of Kite Pharma, Inc. (KITE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul L. Jenkinson has been a net buyer of KITE stock. They have purchased $250.4K and sold $170.3K worth of shares.
Paul L. Jenkinson's most recent insider trade was on Oct 3, 2017, when they sold 9,462 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $180.00 |
| Discretionary |
| Sep 25, 2017 | KITE | $170.3K | Sale | 948 | $179.66 | Discretionary |
| Sep 25, 2017 | KITE | $0 | Award | 2,500 | $N/A | Discretionary |
| May 10, 2017 | KITE | $32.7K | Purchase | 450 | $72.57 | Discretionary |
| May 10, 2017 | KITE | $217.8K | Purchase | 3,000 | $72.59 | Discretionary |
| Dec 22, 2016 | KITE | $0 | Award | 6,600 | $N/A | Discretionary |